Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

A single amino acid change in a neuronal ion channel called KCNQ2 blocks ion flow, prevents protein localization on axons, and results in severe epilepsy and slowed neurological development.